CI-1033 (Canertinib)

inquiry

Cat No.

CEI-0076

Description

CI-1033 (Canertinib) can inhibit EGFR and ErbB2 with IC50 of 1.5 nM and 9.0 nM.

Alias

PD-183805

CAS_No

267243-28-7

Molecular Weight

485.94

Purity

>99%

Storage

2 years at -20centigrade Powder

Synonyms

PD-183805

Targets

EGFR, ErbB2

Molecular Formula

C24H25ClFN5O3

Chemical Name

N-(4-(3-chloro-4-fluorophenylamino)-7-(3-morpholinopropoxy)quinazolin-6-yl)acrylamide

Solubility

DMSO 2 mg/mL Water

In vitro

CI-1033 is an irreversible pan ErbB tyrosine kinase inhibitor, and CI-1033 inhibit all four members of the erbB receptor tyrosine kinase family by binding to the ATP-binding site in the cytoplasmic domain of the EGFR preventing autophosphorylation. CI-1033 inhibits cell proliferation in a dose-dependent manner without induction of apoptosis in human cancer cell lines. CI-1033 signi?cantly suppresses the constitutively activated AKT and the MAP kinases in MDA-MB-453 breast tumor cells.

In vivo

CI-1033 had a growth-inhibitory effect in breast cancer cells, and exposure of SUM-190PT cells to gamma ray irradiation following growth inhibition by CI-1033 enhanced the ef?cacy of ionizing radiation.

Name:

Email *

Phone:*

Company/Institution:

Country or Region:

Quantity:

Services & Products Interested *

Project Description:

Our Products Cannot Be Used As Medicines Directly For Personal Use.

Products

Online Inquiry